The Cellular and Molecular Pathophysiology R&I group undertakes research at the interface between biology and medicine focusing on the pathophysiology of ageing and cardiovascular diseases. Our research aims to advance the understanding of pathological processes, such as atherosclerosis and neurodegeneration, and is applicable to the risk stratification, diagnosis and treatment of common age-related conditions, including stroke, dementia and frailty. Group members have a breadth of expertise, encompassing classic cell and molecular biology, inflammation, cell senescence, vascular biology, biomarker analysis and bioinformatics, which they apply to interrogate in vitro models and clinical cohorts.